Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines
Introduction: Pyridopyrimidines belong to a class of compounds characterized by the presence of nitrogen as heteroatoms. These compounds exhibit diverse biological effects, particularly showing promise as anticancer agents, including actions that inhibit CDK4/6. Methods: We designed and synthesized...
Saved in:
Main Authors: | Chaithra R Shetty, C. S. Shastry, Parasuraman P, Srinivas Hebbar |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2024-07-01
|
Series: | BioImpacts |
Subjects: | |
Online Access: | https://bi.tbzmed.ac.ir/PDF/bi-14-29951.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework
by: Zuokun Lu, et al.
Published: (2024-11-01) -
In Silico and In Vitro Investigation of Cytotoxicity and Apoptosis of Acridine/Sulfonamide Hybrids Targeting Topoisomerases I and II
by: Mohamed Badr, et al.
Published: (2024-11-01) -
Synthesis and cytotoxicity evaluation of thiazole derivatives obtained from 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene- 3-carbonitrile
by: Mohareb Rafat M., et al.
Published: (2017-12-01) -
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer
by: Celina Ablinger, et al.
Published: (2024-12-01) -
In silico identification of novel CDK4 inhibitors for retinoblastoma
by: Mukesh kumar, et al.
Published: (2024-12-01)